Q BioMed Inc. | Income Statement
Fiscal year is December-November. All values USD Thousands.
2014
2015
2016
2017
2018
SG&A Expense
38.10
952.10
6,346.50
12,371.80
9,019.70
EBIT
38.10
952.10
6,346.50
12,371.80
9,019.70
Unusual Expense
-
120.00
303.50
1,409.70
89
Non Operating Income/Expense
-
-
41.30
-
-
Interest Expense
-
14.50
480.30
760.30
162.10
Pretax Income
38.10
1,086.60
7,171.50
14,541.70
9,270.80
Consolidated Net Income
38.10
1,086.60
7,171.50
14,541.70
9,270.80
Net Income
38.10
1,086.60
7,171.50
14,541.70
9,270.80
Net Income After Extraordinaries
38.10
1,086.60
7,171.50
14,541.70
9,270.80
Net Income Available to Common
38.10
1,086.60
7,171.50
14,541.70
9,270.80
EPS (Basic)
0.00
0.12
0.81
1.39
0.67
Basic Shares Outstanding
6,421.20
9,067.80
8,861.20
10,466.60
13,735.10
EPS (Diluted)
0.01
0.12
0.81
1.39
0.67
Diluted Shares Outstanding
6,421.20
9,067.80
8,861.20
10,466.60
13,735.10
EBITDA
38.10
952.10
6,346.50
12,371.80
-
Non-Operating Interest Income
-
-
-
0.10
-
About Q BioMed
View Profile
